Literature DB >> 2496687

Characterization of G25K, a GTP-binding protein containing a novel putative nucleotide binding domain.

P G Polakis1, R Snyderman, T Evans.   

Abstract

Amino acid sequences were obtained for four peptides (p1, -2, -3 and 4) generated by chemical or proteolytic cleavage of a 25 kDa GTP-binding protein purified from human placental and platelet membranes. The peptides shared sequence similarities with those contained in several of the ras-related GTP-binding proteins. Peptide p2, a 12-mer, was homologous with a region of the GTP-binding proteins that contains a structural motif proposed to contribute to the nucleotide binding site. However, whereas nearly all GTP-binding proteins exhibit the residues NKXD as this motif, p2 contains TQID. Antisera (Ap1 and Ap3) raised against synthetic peptides corresponding to p1 and p3 specifically reacted on Western blots with the 25 kDa GTP-binding protein purified from human placenta, human platelet and bovine brain as well as with a 25 kDa polypeptide in various cell lines. These results demonstrate the widespread existence of an abundant 25 kDa GTP-binding protein which contains a putative nucleotide binding domain that is chemically distinct from that described for all GTP-binding proteins of known primary structure.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2496687     DOI: 10.1016/0006-291x(89)91615-x

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  13 in total

1.  Characterization of four novel ras-like genes expressed in a human teratocarcinoma cell line.

Authors:  G T Drivas; A Shih; E Coutavas; M G Rush; P D'Eustachio
Journal:  Mol Cell Biol       Date:  1990-04       Impact factor: 4.272

2.  Association of the GTP-binding protein Rab3A with bovine adrenal chromaffin granules.

Authors:  F Darchen; A Zahraoui; F Hammel; M P Monteils; A Tavitian; D Scherman
Journal:  Proc Natl Acad Sci U S A       Date:  1990-08       Impact factor: 11.205

3.  Molecular cloning of the gene for the human placental GTP-binding protein Gp (G25K): identification of this GTP-binding protein as the human homolog of the yeast cell-division-cycle protein CDC42.

Authors:  K Shinjo; J G Koland; M J Hart; V Narasimhan; D I Johnson; T Evans; R A Cerione
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

Review 4.  Cdc42: An essential Rho-type GTPase controlling eukaryotic cell polarity.

Authors:  D I Johnson
Journal:  Microbiol Mol Biol Rev       Date:  1999-03       Impact factor: 11.056

5.  Spreading of differentiating human monocytes is associated with a major increase in membrane-bound CDC42.

Authors:  M Aepfelbacher; F Vauti; P C Weber; J A Glomset
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-10       Impact factor: 11.205

6.  Purification of a plasma membrane-associated GTPase-activating protein specific for rap1/Krev-1 from HL60 cells.

Authors:  P G Polakis; B Rubinfeld; T Evans; F McCormick
Journal:  Proc Natl Acad Sci U S A       Date:  1991-01-01       Impact factor: 11.205

7.  Purification and N-terminal sequence of the p21rho GTPase-activating protein, rho GAP.

Authors:  M D Garrett; G N Major; N Totty; A Hall
Journal:  Biochem J       Date:  1991-06-15       Impact factor: 3.857

8.  Membrane-binding domain of the small G protein G25K contains an S-(all-trans-geranylgeranyl)cysteine methyl ester at its carboxyl terminus.

Authors:  H K Yamane; C C Farnsworth; H Y Xie; T Evans; W N Howald; M H Gelb; J A Glomset; S Clarke; B K Fung
Journal:  Proc Natl Acad Sci U S A       Date:  1991-01-01       Impact factor: 11.205

9.  Mutational analysis of CDC42Sc, a Saccharomyces cerevisiae gene that encodes a putative GTP-binding protein involved in the control of cell polarity.

Authors:  M Ziman; J M O'Brien; L A Ouellette; W R Church; D I Johnson
Journal:  Mol Cell Biol       Date:  1991-07       Impact factor: 4.272

Review 10.  Rho GTPases in platelet function.

Authors:  J E Aslan; O J T McCarty
Journal:  J Thromb Haemost       Date:  2013-01       Impact factor: 5.824

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.